Improved Diagnostic Capabilities for Select Biodefense and Emerging Pathogens (R21/R33)

The summary for the Improved Diagnostic Capabilities for Select Biodefense and Emerging Pathogens (R21/R33) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Improved Diagnostic Capabilities for Select Biodefense and Emerging Pathogens (R21/R33): To support basic to translational research focused on development of improved and/or field-appropriate diagnostic capabilities for select biodefense and emerging pathogens.

Federal Grant Title:	Improved Diagnostic Capabilities for Select Biodefense and Emerging Pathogens (R21/R33)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-AI-11-024
Type of Funding:	Grant
CFDA Numbers:	93.855
CFDA Descriptions:	Allergy, Immunology and Transplantation Research
Current Application Deadline:	Jul 14, 2011
Original Application Deadline:	Jul 14, 2011
Posted Date:	Mar 17, 2011
Creation Date:	Mar 17, 2011
Archive Date:	Aug 14, 2011
Total Program Funding:	$4,000,000
Maximum Federal Grant Award:	$200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Foreign (non-U.S.) components of U.S. Organizations are allowed.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed); • NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed); • Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed); • Coccidioidomycosis Collaborative Research Centers (P01 Clinical Trial Not Allowed); • Impact of Initial Influenza Exposure on Immunity in Infants (U01 Clinical Trial Not Allowe...; • Center for HIV/AIDS Vaccine Immunology (CHAVI); • Genomics of Transplantation Cooperative Research Program; • Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health: • The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Lab...; • The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations ...; • NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed); • Single Source: Accelerating Medicines Partnership Schizophrenia (AMP SCZ): Data Processing...; • NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)